Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
American Journal of Clinical Pathology|September 19, 2009
Plasmablastic lymphomas with MYC/IgH rearrangement: report of three cases and review of the literatureAgata M Bogusz, Adam C Seegmiller, Rolando Garcia, et al.
Journal of Pediatric Hematology/Oncology|June 27, 2013
Idiopathic myelofibrosis in children: primary myelofibrosis, essential thrombocythemia, or transient process?Jeremy S Slone, Megan C Smith, Adam C Seegmiller, et al.
American Journal of Hematology|December 24, 2017
A distinct immunophenotype identifies a subset of NPM1-mutated AML with TET2 or IDH1/2 mutations and improved outcomeEmily F Mason, Frank C Kuo, Robert P Hasserjian, et al.
Cytometry. Part B, Clinical Cytometry|October 29, 2008
Overexpression of CD7 in classical Hodgkin lymphoma-infiltrating T lymphocytesAdam C Seegmiller, Nitin J Karandikar, Steven H Kroft, et al.
Cognition|April 5, 2021
Disentangling prevalence induced biases in medical image decision-makingJennifer S Trueblood, Quentin Eichbaum, Adam C Seegmiller, et al.
Developmental Cell|February 8, 2002
The SREBP pathway in Drosophila: regulation by palmitate, not sterolsAdam C Seegmiller, Irina Dobrosotskaya, Joseph L Goldstein, et al.
American Journal of Clinical Pathology|March 15, 2018
Limited Utility of Fluorescence In Situ Hybridization for Recurrent Abnormalities in Acute Myeloid Leukemia at Diagnosis and Follow-upFerrin C Wheeler, Annette S Kim, Claudio A Mosse, et al.
Journal of Hematopathology|March 3, 2026
Histopathologic findings of tularemia lymphadenitisAnna Dar, Ritu Banerjee, Emily F Mason
Plos One|April 14, 2016
High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic Changes in Persistent Cells during Induction TherapyPaul Brent Ferrell, Kirsten Elizabeth Diggins, Hannah Grace Polikowsky, et al.
Pageof 5